Showing results (1001-1010 of 1,520) with videos related to

Sort By:
Pageof 152
The Lancet. Oncology|October 17, 2017
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trialTomasz M Beer, Sebastien J Hotte, Fred Saad, et al.
Surgical Endoscopy|September 24, 1998
Pneumoperitoneum risk prognosis and correction of venous circulation disturbances in laparoscopic surgery. A pilot studyS I Emeljanov, V V Fedenko, E M Levite, et al.
Biomolecules|January 25, 2025
Synthesis and Anti-Cancer Activity In Vitro of Synephrine DerivativesEkaterina M Zhidkova, Evgeniya S Oleynik, Ekaterina A Mikhina, et al.
Dalton Transactions (Cambridge, England : 2003)|February 25, 2026
Polysubstituted guanidine-based receptors for the selective extraction of pertechnetate anions from high-level wasteUliana M Leksina, Vladimir A Abramov, Petr I Matveev, et al.
Case Reports in Oncology|October 27, 2021
Comprehensive Molecular Genetic Diagnostics of Birt-Hogg-Dube Syndrome in a Russian Patient with Renal Cancer and Lung Cysts: A Case ReportDmitry S Mikhaylenko, Vsevolod B Matveev, Margarita G Filippova, et al.
Inorganic Chemistry|September 21, 2021
Way to Enforce Selectivity via Steric Hindrance: Improvement of Am(III)/Eu(III) Solvent Extraction by Loaded Diphosphonic Acid EstersPetr I Matveev, Pin-Wen Huang, Anna A Kirsanova, et al.
Targeted Oncology|April 7, 2021
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer RegistryAnders Bjartell, Nicolaas Lumen, Pablo Maroto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancerG Sonpavde, V Matveev, J M Burke, et al.
Cancers|April 3, 2021
miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell CarcinomaHiresh Ayoubian, Joana Heinzelmann, Sebastian Hölters, et al.
Nature Nanotechnology|November 16, 2021
Electronic thermal transport measurement in low-dimensional materials with graphene non-local noise thermometryJonah Waissman, Laurel E Anderson, Artem V Talanov, et al.
Pageof 152